Astellas

Corporate Communications chief of Astellas, Jo Taylor moves to Cello Health Communications

https://pharmaphorum.com/partner-content/corporate-communications-chief-of-astellas-jo-taylor-moves-to-cello-health-communications/

UK’s KaNDy Therapeutics funds mid-stage trial of HRT ‘replacement’

https://pharmaphorum.com/news/uks-kandy-therapeutics-funds-mid-stage-trial-of-hrt-replacement/

Astellas buys eye gene therapy biotech Quethera for $109m

https://pharmaphorum.com/news/astellas-expands-ocular-gene-therapy-investment/

Seattle Genetics and Astellas gain Breakthrough Designation for urothelial cancer treatment

https://pharmaphorum.com/news/seattle-genetics-astellas-gain-breakthrough-designation-urothelial-cancer-treatment/

Wayward Astellas comes close to UK industry expulsion

https://pharmaphorum.com/news/astellas-suspended-uk-pharma-body-year/

Astellas buys Ogeda after menopause drug impresses

https://pharmaphorum.com/news/astellas-buys-ogeda-menopause-drug-impresses/

Astellas wins first Real-World Evidence prize at UK awards

https://pharmaphorum.com/views-and-analysis/astellas-wins-first-real-world-evidence-prize-uk-awards/

Astellas censured for breach of ABPI code

https://pharmaphorum.com/transversal-categories/uk-and-europe/astellas-censured-for-breach-of-abpi-code/

Astellas files new drug for life-threatening infections

https://pharmaphorum.com/news/astellas-files-new-drug-for-life-threatening-infections/

Close in 10 seconds

Pharmaphorum.com

Search